* Voltaren 50 (diclofenac natrium) 20 enteric coated tablets 50 mg. Antirheumatic, anti-inflammatory, analgesic. * Composition: Each enteric coated tablet contains: & & Sodium {o-{(2,6-dichlorophenyl)-amino} – phenyl} – acetate = diclofenac sodium 50 mg and excipients. * Therapeutic Indications: Treatment of: & & – inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, & & osteoarthritis, spondylarthritis, painful syndromes of the vertebral coulmn, non-articular rheumatism. & & – acute attacks of gout. & & – post-traumatic and postoperative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery. & & – painful and/or inflammatory conditions in gynaecology , e.g. primary dysmenorrhoea or adnexitis. & & – as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otits. & & In keeping with standard therapeutic principles, the underlying disease should be treated with specific therapy, as appropriate. & & Fever alone is not an indication. * Psology and method of administration: & & – Adults: The recommended initial daily dosage is 100-150 mg. In milder cases, as well as for long-term therapy, 75-100 mg daily & & is usually sufficient. The total daily dosage should be divided into 2-3 doses. To suppress nocturnal pain and morning stiffness, & & treatment with tablets during the day can be supplemented by the administration of a suppository at bedtime (up to a maximum & & daily dose of 150 mg). In primary dysmenorrhoea the daily dosage should be individually adjusted and is generally 50-150 mg. & & Initially a dose of 50-100 mg should be given and, if necessary, raised in the course of several menstrual cycles up to & & a maximum of 200 mg/day. Treatment should be started upon appearance of the first symptoms and depending on the & & symptomatology, continued for a few days. The tablets should be swallowed whole with liquid, preferably before meals. & & – Children: Children aged 1 year and over should be given 0.5-2 mg/kg body weight daily, in 2-3 divided doses, depending on & & the severity of the disorder. Fo the treatment of juvenile rheumatoid arthritis the daily dosage can be raised up to a maximum & & of 3 mg/kg in divided doses.Voltaren tablets of 50 mg are not recommended for use in children. * Contraindications: & & – Gastric or intestinal ulcer. & & – Known hypersensitivity to the active substance and any of the excipients. & & – Like other non-steroidal anti-inflammatory drugs (NSAIDs), Voltaren is also contraindicated in patients in whom attacks & & of asthma, urticaria, or acute rhinitis are precipitated by acetylsalicylic acid or other drugs with prostaglandin-synthetase & & inhibiting activity. * To be used under medical supervision. To be swallowed whole. * Protect from light and heat (Store below 30 degrees C). * Produced by: NOVARTIS PHARMA S.A.E. Cairo, under license from: Novartis Pharma AG., Basle, Switzerland.